Regular Aspirin Use May Protect Against Bile Duct Cancer

This article originally appeared here.
Regular Aspirin Use May Protect Against Bile Duct Cancer
Regular Aspirin Use May Protect Against Bile Duct Cancer

(HealthDay News) -- Regular aspirin use may lower the risk of bile duct cancer, according to a study published online April 26 in Hepatology.

The study included 2,395 bile duct cancer patients and a control group of 4,769 individuals without the cancer. About 25 percent of the bile duct cancer patients and 45 percent of those in the control group took aspirin.

The authors found that, overall, people who took aspirin were roughly three times less likely to develop bile duct cancer than those who did not take aspirin. The findings do not prove that aspirin caused the risk of bile duct cancer to drop. However, "chronic persistent inflammation is one of the key elements that promotes cancer of the bile ducts, and well-known risk factors for bile duct cancer have all been shown to increase the risk for bile duct cancer by inducing chronic inflammation of the ducts," study coauthor Jonggi Choi, M.B., Ch.B., Ph.D., of the Mayo Clinic College of Medicine in Rochester, Minn., said in a journal news release.

The findings suggest that further research on the potential for aspirin to prevent bile duct cancer is warranted, the study authors said.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs